Nafamostat mesylate, a serine protease inhibitor, demonstrates novel antimicrobial properties and effectiveness in Chlamydia-induced arthritis Full Text
Arthritis Research & Therapy, 07/05/2012
Inman RD et al. – Nafamostat mesylate (NM) is a protease inhibitor not previously recognized to possess antimicrobial properties. The present study demonstrates for the first time that NM exerts significant impact on Chlamydia trachomatis–induced arthritis and suggests that such approaches may prove clinically useful in chronic reactive arthritis.